| Effects of diltiazem on the electrophysiological properties of cat ventricular muscle fibers during experimentally induced right ventricular systolic hypertension. | |
| | |
MedLine Citation:
|
PMID: 6185793 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The electrophysiological effects of diltiazem were studied in right ventricular muscle fibers from normal cats and cats with experimentally induced right ventricular systolic hypertension (RVSH). Two types of action potential (AP) abnormalities were observed in preparations from cats with RVSH: Type I cells, found in most areas of the right ventricular free wall, demonstrated reduced maximum diastolic potential (MDP) (-64.4 mV) and Vmax (89.6 V/s) while Type II cells showed a "slow response" AP configuration (MDP, -48.8 mV; AP amplitude, 48.9 mV; AP duration at 50% repolarization, 47.5 ms; AP duration at 90% repolarization, 90.2 ms; Vmax, 13.1 V/s) and were often monitored near the tricuspid valve. Diltiazem (2.2 X 10(-7) and 2.2 X 10(-6) M) had no effect on MDP of normal, Type I, or Type II cells. Diltiazem at 2.2 X 10(-6) M significantly reduced AP amplitude and Vmax of both Type I and normal cells. In contrast, even at 2.2 X 10(-7) M, diltiazem significantly reduced AP amplitude and Vmax of the Type II cells. Diltiazem, 2.2 X 10(-6) M, would often abolish AP of Type II cells, while Type I cells were more sensitive to tetrodotoxin. AP duration of normal cells was unaffected by diltiazem while that of Type I and II cells was significantly shortened. |
| | |
Authors:
|
S S Wong; R J Myerburg; A M Ezrin; M S Gaide; A L Bassett |
Related Documents
:
|
12948593 - Cell swelling activates cloned ca(2+)-activated k(+) channels: a role for the f-actin c... 2297813 - Electrophysiological properties and responses to simulated ischemia in cat ventricular ... 11428653 - Triton-x-100-modified polymer and microspheres for reversal of multidrug resistance. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Journal of cardiovascular pharmacology Volume: 4 ISSN: 0160-2446 ISO Abbreviation: J. Cardiovasc. Pharmacol. Publication Date: 1982 Nov-Dec |
Date Detail:
|
Created Date: 1983-03-11 Completed Date: 1983-03-11 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 7902492 Medline TA: J Cardiovasc Pharmacol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 986-93 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Action Potentials
/
drug effects Animals Benzazepines / pharmacology* Blood Pressure / drug effects* Cats Diltiazem / pharmacology* Electrophysiology Heart / drug effects*, physiology Heart Ventricles Hypertension / drug therapy* |
| Grant Support | |
ID/Acronym/Agency:
|
HL 19044/HL/NHLBI NIH HHS; HL 21735/HL/NHLBI NIH HHS; HL 27680/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Benzazepines; 42399-41-7/Diltiazem |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In vivo disposition of prostaglandin E1 via pharmacokinetic characterization of its pulmonary metabo...
Next Document: Effects of disopyramide on reperfusion arrhythmias in dogs.